莱茵生物：8月27日召开董事会会议

Group 1 - The company, Rhine Biotech (SZ 002166), announced that its seventh board meeting for 2025 was held on August 27, 2025, to review the special report on the use of raised funds for the first half of 2025 [1] - For the year 2024, the company's revenue composition was 97.47% from manufacturing and 2.53% from other industries [1]